tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NRx Pharmaceuticals Reports Progress in Drug Development Amid Financial Challenges
PremiumCompany AnnouncementsNRx Pharmaceuticals Reports Progress in Drug Development Amid Financial Challenges
9d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs
10d ago
Nrx Pharmaceuticals Faces Financing Hurdles in Strategic Acquisitions of Kadima and Dura Medical
Premium
Company Announcements
Nrx Pharmaceuticals Faces Financing Hurdles in Strategic Acquisitions of Kadima and Dura Medical
11d ago
NRx Pharmaceuticals Delays Q2 2025 Report Filing
PremiumCompany AnnouncementsNRx Pharmaceuticals Delays Q2 2025 Report Filing
15d ago
Psychedelic: atai Life Sciences, Cybin report earnings results
Premium
The Fly
Psychedelic: atai Life Sciences, Cybin report earnings results
15d ago
Is NRXP a Buy, Before Earnings?
Premium
Pre-Earnings
Is NRXP a Buy, Before Earnings?
17d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products
25d ago
NRx files Citizen Petition with FDA seeking removal of BZT from ketamine
Premium
The Fly
NRx files Citizen Petition with FDA seeking removal of BZT from ketamine
25d ago
NRX Pharmaceuticals’ Innovative Approaches in Mental Health Treatment Drive Buy Rating
Premium
Ratings
NRX Pharmaceuticals’ Innovative Approaches in Mental Health Treatment Drive Buy Rating
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100